Osteoarthritis endotype discovery via clustering of biochemical marker dataFederico Angelini, Paweł Widera, Ali Mobasheri, Joseph Blair, André Struglics, Melanie Uebelhoer, Yves Henrotin, Anne CA Marijnissen, Margreet Kloppenburg, Francisco J Blanco, Ida K Haugen, Francis Berenbaum, Christoph Ladel, Jonathan Larkin, Anne C Bay-JensenSee the full list of authors
4 March 2022
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, Rudolf Debelak, Kim Fligelstone, Ann Tyrrell Kennedy, Annelise Roennow, Yannick Allanore, Patricia E Carreira, László Czirják, Christopher P Denton, Roger Hesselstrand, Gunnel Sandqvist, Otylia Kowal-Bielecka, Cosimo BruniSee the full list of authors
25 November 2021
Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort studyAlejandro Balsa, Maria Jesus García de Yébenes, Loreto Carmona, , ADHIERA Study Group, Laura Garrido Courel, Javier Mendizábal, Juliana Restrepo, Dolores Fábregas, Joana Atxotegi Saenz de Buruaga, Javier Duruelo Etxebarrieta, Nathali Rivas Zavaleta, Eugenio Chamizo Carmona, Lara Chaves, Sara RojasSee the full list of authors
29 November 2021
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasisPaolo Gisondi, Francesco Bellinato, Giovanni Targher, Luca Idolazzi, Giampiero Girolomoni
18 June 2021
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritisAnthony James Ocon, George Reed, Dimitrios A Pappas, Jeffrey R Curtis, Joel M Kremer
2 July 2021
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritisTate M Johnson, Harlan R Sayles, Joshua F Baker, Michael D George, Punyasha Roul, Cheng Zheng, Brian Sauer, Katherine P Liao, Daniel R Anderson, Ted R Mikuls, Bryant R England
28 May 2021
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseasesMarcia A Friedman, Jeffrey R Curtis, Kevin L Winthrop
7 September 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, Milena A Gianfrancesco, Zara Izadi, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus, Saskia Lawson-Tovey, Laura Trupin, Stephanie Rush, Patricia Katz, Gabriela SchmajukSee the full list of authors
28 May 2021
Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020Wenhui Xie, Hong Huang, Guangtao Li, Yanjie Hao, Yanni Gui, Yu Wang, Xuerong Deng, Juan Zhao, Yan Geng, LanLan Ji, Xiaohui Zhang, Zhibo Song, Zhuoli Zhang
2 April 2021
Genetic variants shape rheumatoid arthritis-specific transcriptomic features in CD4 T cells through differential DNA methylation, explaining a substantial proportion of heritabilityEunji Ha, So-Young Bang, Jiwoo Lim, Jun Ho Yun, Jeong-Min Kim, Jae-Bum Bae, Hye-Soon Lee, Bong-Jo Kim, Kwangwoo Kim, Sang-Cheol Bae
12 January 2021
